Medibank Pvt Ltd (ASX: MPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medibank Pvt Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$14.16 billion
P/E Ratio
21.85
Dividend Yield
3.79%
Shares Outstanding
2.75 billion
Earnings per share
0.232
Dividend per share
0.19
Year To Date Return
9.85%
Earnings Yield
4.58%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medibank Pvt Ltd (ASX: MPL)
Latest News
Dividend Investing
2 ASX dividend shares I'd use to generate $500 a month in 2027
Broker Notes
Buy, hold, sell: Nick Scali, Medibank Private, BHP shares
Healthcare Shares
Forget term deposits! I'd buy these ASX dividend shares instead
Broker Notes
Buy, hold, sell: Ramelius Resources, Medibank, Soul Patts shares
Dividend Investing
Insurance Australia Group vs Medibank: Which is the more reliable passive income stock?
Superannuation
How much passive income can I earn off a $700,000 superannuation balance?
Healthcare Shares
I'd buy 6,462 shares of this ASX stock to aim for $200 a month of passive income
Superannuation
How much superannuation do I need to generate $100,000 per year in passive income?
ASX Share Market News
5 things to watch on the ASX 200 on Thursday
Opinions
Where I'd invest in ASX shares after the recent RBA rate rise
Healthcare Shares
Is the Medibank share price a buy for its 6% dividend yield?
Superannuation
How much is needed in superannuation to target a $10,000 monthly passive income?
Frequently Asked Questions
-
Medibank Private was established by the Australian government in 1976 as a not-for-profit private health insurer. It converted into a for-profit entity in 2009 before listing on the ASX in November 2014.
-
Yes, Medibank Private has paid dividends to shareholders every year since 2015. Typically, it pays an interim dividend in March and a final dividend in September, both fully franked.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 02 Sep 2026 | $0.1090 | 100.00% | Final | 08 Oct 2026 |
| 26 Feb 2026 | $0.0830 | 100.00% | Interim | 18 Mar 2026 |
| 10 Sep 2025 | $0.1020 | 100.00% | Final | 09 Oct 2025 |
| 06 Mar 2025 | $0.0780 | 100.00% | Interim | 26 Mar 2025 |
| 04 Sep 2024 | $0.0940 | 100.00% | Final | 26 Sep 2024 |
| 29 Feb 2024 | $0.0720 | 100.00% | Interim | 20 Mar 2024 |
| 13 Sep 2023 | $0.0830 | 100.00% | Final | 05 Oct 2023 |
| 02 Mar 2023 | $0.0630 | 100.00% | Interim | 22 Mar 2023 |
| 07 Sep 2022 | $0.0730 | 100.00% | Final | 29 Sep 2022 |
| 04 Mar 2022 | $0.0610 | 100.00% | Interim | 24 Mar 2022 |
| 08 Sep 2021 | $0.0690 | 100.00% | Final | 30 Sep 2021 |
| 03 Mar 2021 | $0.0580 | 100.00% | Interim | 25 Mar 2021 |
| 02 Sep 2020 | $0.0630 | 100.00% | Final | 24 Sep 2020 |
| 03 Mar 2020 | $0.0570 | 100.00% | Interim | 26 Mar 2020 |
| 04 Sep 2019 | $0.0740 | 100.00% | Final | 26 Sep 2019 |
| 05 Mar 2019 | $0.0570 | 100.00% | Interim | 28 Mar 2019 |
| 05 Sep 2018 | $0.0720 | 100.00% | Final | 27 Sep 2018 |
| 06 Mar 2018 | $0.0550 | 100.00% | Interim | 28 Mar 2018 |
| 06 Sep 2017 | $0.0000 | 100.00% | Final | 28 Sep 2017 |
| 07 Mar 2017 | $0.0525 | 100.00% | Interim | 29 Mar 2017 |
| 06 Sep 2016 | $0.0600 | 100.00% | Final | 28 Sep 2016 |
| 04 Mar 2016 | $0.0500 | 100.00% | Interim | 29 Mar 2016 |
MPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Medibank Pvt Ltd
Previously owned by the Australian government, Medibank Private Ltd (ASX: MPL) is the largest health insurer in Australia.
As of November 2022, its two brands, Medibank Private and ahm, provide cover to almost five million people.
Medibank and Australia's fourth-largest health fund, NIB Holdings Limited (ASX: NIB), are the only health insurers listed on the ASX.
In addition to private health insurance, the company provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
MPL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 03 Nov 2026 | $5.14 | $0.07 | 1.38% | 9,645,299 | $5.05 | $5.14 | $5.05 |
| 02 Nov 2026 | $5.07 | $-0.02 | -0.39% | 9,401,521 | $5.10 | $5.16 | $5.07 |
| 30 Oct 2026 | $5.09 | $0.08 | 1.60% | 6,826,329 | $5.05 | $5.15 | $5.04 |
| 29 Oct 2026 | $5.01 | $0.10 | 2.04% | 5,674,779 | $4.97 | $5.05 | $4.90 |
| 28 Oct 2026 | $4.91 | $-0.14 | -2.77% | 8,364,305 | $5.00 | $5.04 | $4.93 |
| 27 Oct 2026 | $5.05 | $0.00 | 0.00% | 6,772,328 | $5.04 | $5.06 | $5.01 |
| 26 Oct 2026 | $5.05 | $0.06 | 1.20% | 7,840,833 | $4.97 | $5.10 | $4.91 |
| 23 Oct 2026 | $4.99 | $0.06 | 1.22% | 9,045,340 | $4.96 | $4.99 | $4.91 |
| 22 Oct 2026 | $4.93 | $0.10 | 2.07% | 6,229,665 | $4.83 | $4.94 | $4.82 |
| 21 Oct 2026 | $4.83 | $0.05 | 1.05% | 5,305,677 | $4.81 | $4.86 | $4.79 |
| 20 Oct 2026 | $4.78 | $0.03 | 0.63% | 4,692,327 | $4.73 | $4.80 | $4.71 |
| 19 Oct 2026 | $4.75 | $0.01 | 0.21% | 5,507,477 | $4.75 | $4.81 | $4.70 |
| 16 Oct 2026 | $4.74 | $-0.04 | -0.84% | 9,094,153 | $4.80 | $4.81 | $4.73 |
| 15 Oct 2026 | $4.78 | $0.12 | 2.58% | 9,754,692 | $4.71 | $4.82 | $4.70 |
| 14 Oct 2026 | $4.66 | $-0.02 | -0.43% | 6,739,658 | $4.66 | $4.69 | $4.62 |
| 13 Oct 2026 | $4.68 | $0.04 | 0.86% | 6,061,396 | $4.64 | $4.69 | $4.62 |
| 12 Oct 2026 | $4.64 | $0.00 | 0.00% | 3,313,517 | $4.63 | $4.65 | $4.59 |
| 09 Oct 2026 | $4.64 | $0.07 | 1.53% | 4,833,186 | $4.57 | $4.64 | $4.57 |
| 08 Oct 2026 | $4.57 | $0.02 | 0.44% | 6,956,537 | $4.55 | $4.60 | $4.54 |
| 07 Oct 2026 | $4.55 | $0.02 | 0.44% | 3,453,864 | $4.51 | $4.56 | $4.50 |
| 06 Oct 2026 | $4.53 | $0.03 | 0.67% | 3,838,612 | $4.51 | $4.55 | $4.49 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 01 Sep 2026 | David Koczkar | Expiry | 158,900 | $764,309 |
As advised by the company. 2,051,628 Performance Rights, lapsing of Rights
|
| 01 Sep 2026 | David Koczkar | Buy | 65,073 | $313,001 |
Conversion of securities.
|
| 01 Sep 2026 | David Koczkar | Exercise | 65,073 | $313,001 |
Conversion of securities. 2,210,528 Performance Rights
|
| 24 Aug 2026 | Jacqueline Hey | Buy | 14,000 | $14,000 |
On-market trade.
|
| 02 Mar 2026 | Jacqueline Hey | Buy | 11,448 | $50,600 |
On-market trade.
|
| 27 Feb 2026 | Peter Everingham | Buy | 25,000 | $110,250 |
On-market trade.
|
| 23 Feb 2026 | Lisa McIntyre | Buy | 22,370 | $100,217 |
On-market trade.
|
| 23 Dec 2025 | David Koczkar | Transfer | 535,832 | $2,550,560 |
Off-market transfer.
|
| 23 Dec 2025 | David Koczkar | Transfer | 535,832 | $2,550,560 |
Off-market transfer.
|
| 12 Dec 2025 | David Koczkar | Issued | 724,646 | $3,398,589 |
Issue of securities. 2,275,601 Performance Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Michael (Mike) John Wilkins | Non-Executive DirectorNon-Executive Chairman | May 2017 |
Mr Wilkins has more than 30 years of experience in financial services, predominantly in Australia and Asia. He is a member of the Investment and Capital Committee and the People committee.
|
| Ms Kathryn Joy Fagg | Non-Executive Director | Mar 2022 |
Ms Fagg is a director and Chair with senior commercial and operational experience. She is Chair of the Risk Management Committee.
|
| Dr Lisa Margaret McIntyre | Non-Executive Director | Nov 2025 |
Dr McIntyre is an experienced company director with a portfolio that spans the health, insurance, technology and e-learning sectors. Lisa's executive experience is primarily in strategy. She spent 20 years as a Senior Partner at L.E.K. Consulting, in its health and biotechnology practices in the US and Australia. She is a member of the Investment and Capital Committee and the People committee.
|
| Ms Jacqueline Cherie Hey | Non-Executive Director | Nov 2025 |
Ms Hey is an experienced non-executive director with experience in consumer businesses and the financial services and technology sectors. Jacquie's prior professional experience includes more than 20 years with IT and telecommunications company Ericsson where she held multiple senior positions globally and in Australia. She is a member of the Risk Management Committee.
|
| Mr David Koczkar | Chief Executive OfficerManaging Director | May 2021 |
Mr Koczkar has over 25 years of leadership experience across Australia, Asia and the UK, including previous work in the aviation, consulting and financial services industries. David joined Medibank in 2014 as Chief Operating Officer and then Group Executive - Chief Customer Officer from September 2016, responsible for the Medibank and ahm Health Insurance and Wellbeing portfolios.
|
| Mr Peter Dobie Everingham | Non-Executive Director | Mar 2022 |
Mr Everingham has over 25 years of corporate experience having held senior executive roles in that sector for 18 years. His senior leadership experience includes roles at companies with a consumer and technology focus. He is the Chair of the Investment and Capital Committee and a member of the People Committee.
|
| Dr Tracey Leigh Batten | Non-Executive Director | Aug 2017 |
Dr Batten has experience in the health services sector, with commercial, strategy, and change leadership skills. She is the Chair of the People Committee and a member of the Risk Management Committee.
|
| Mr Gerard Dalbosco | Non-Executive Director | May 2021 |
Mr Dalbosco has held several senior leadership roles including Oceania Managing Partner and CEO; Asia Pacific Joint Deputy CEO and Managing Partner - Markets; Oceania Managing Partner - Transaction Advisory Services; and Melbourne Managing Partner. Prior to these roles Gerard advised organizations across a range of sectors in respect of merger and acquisitions advice, valuations, and strategic, commercial and financial due diligence. He is a member of the Risk Management committee.
|
| Ms Mei Ramsay | Group General CounselCompany Secretary | Mar 2011 |
-
|
| Mei Ramsay | Group General CounselCompany Secretary |
-
|
|
| Robert Read | Group Lead - Amplar Health |
-
|
|
| Mark Rogers | Group Lead - CFO & Group Strategy |
-
|
|
| Felicia Trewin | Group Lead - Data & Technology |
-
|
|
| Milosh Milisavljevic | Group Lead - Other Executive Office |
-
|
|
| Kylie Bishop | Group Lead - People Spaces & Sustainability |
-
|
|
| Meaghan Telford | Group Lead - Policy Advocacy & Reputation |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 809,761,773 | 29.40% |
| J P Morgan Nominees Australia Pty Limited | 703,735,638 | 25.55% |
| Citicorp Nominees Pty Limited | 390,937,043 | 14.20% |
| BNP Paribas Noms Pty Ltd | 74,765,437 | 2.71% |
| BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 66,261,112 | 2.41% |
| HSBC Custody Nominees (Australia) Limited <Ntcomnwlth Super Corp A/C> | 20,023,279 | 0.73% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 11,647,566 | 0.42% |
| Netwealth Investments Limited <Wrap Services A/C> | 8,519,960 | 0.31% |
| Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 7,378,274 | 0.27% |
| BNP Paribas Noms (Nz) Ltd | 7,107,368 | 0.26% |
| HSBC Custody Nominees (Australia) Limited i | 4,938,591 | 0.18% |
| Ioof Investment Services Limited <Ips Superfund A/C> | 4,288,956 | 0.16% |
| Boardroom Financial Services Pty Limited <Vsa Unrestricted A/C> | 4,124,724 | 0.15% |
| Netwealth Investments Limited <Super Services A/C> | 3,744,033 | 0.14% |
| UBS Nominees Pty Ltd | 3,252,507 | 0.12% |
| Ioof Investment Services Limited <Iisl Nal Isma 2 A/C> | 3,185,796 | 0.12% |
| HSBC Custody Nominees (Australia) Limited Gsco Eca | 2,529,824 | 0.09% |
| Ioof Investment Services Limited <Ioof Idps A/C> | 2,456,566 | 0.09% |
| Olive Man Investments Pty Ltd <Olive Man A/C> | 2,420,503 | 0.09% |
| Ioof Investment Services Limited <Iisl Nal Isma 1 A/C> | 1,587,382 | 0.04% |
